You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
Magnetic Resonance Spectroscopy in Gliobastoma
- Disease
- colorectal cancer
- Drug Name
- RECENTIN
- Generic Name
- AZD2171
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Aug 31, 2007
- Study Name
- IRUS21710033
- Study Id
- IRUS21710033
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
